NCT05949476

Brief Summary

Patients will undergo a split-mouth protocol which includes: a control group: in which the extraction of the lower third molar will be performed according to the standard protocols of the structure. A study group: in which ozone will be used in addition, in two formulations: gaseous, injected into the site of the pre- and post-surgery operation, and topical, in the form of a gel, applied at the end of the operation and for home use according to therapeutic scheme prescribed at the time of discharge. Primary objective: To evaluate whether the use of ozone in patients undergoing extraction of impacted third molars reduces post-operative pain 7 days after surgery. Secondary objectives:

  • Evaluate the functional limitation in opening the mouth (trismus) 7 days after surgery.
  • Evaluate if there is a reduced intake of analgesic drugs in the 7 days following the operation.
  • Evaluate the perceived quality of life in the 7 days following the intervention.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 19, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

July 10, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 18, 2023

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 19, 2023

Completed
Last Updated

July 18, 2023

Status Verified

July 1, 2023

Enrollment Period

12 months

First QC Date

July 10, 2023

Last Update Submit

July 10, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reduction post operative pain

    Evaluate whether the use of ozone in patients undergoing extraction of impacted third molars reduces post-operative pain 7 days after surgery.

    7 days

Study Arms (2)

Control Group

NO INTERVENTION

extraction of the lower third molar will be performed according to the standard protocols of the structure

Trial Group

EXPERIMENTAL

In this group ozone will be used, in two formulations: gaseous, injected into the site of the pre- and post-surgery operation, and topical, in the form of a gel, applied at the end of the operation and for home use according to the therapeutic scheme prescribed at the time of resignation

Other: ozone therapy

Interventions

Ozone in the gaseous state produced by a machine at concentrations for medical use (sssssssssss9) injected after anesthesia in the surgery site and in the post-extraction alveolus after suture. * Topical ozone in the form of a gel (indicate the brand) to be applied to the post-surgical site 2 times a day for 7 days.

Trial Group

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Lower third molars included
  • Pell-Gregory Class II-B
  • Absence of systemic diseases

You may not qualify if:

  • Hyperthyroidism;
  • G6PHD (glucose 6 phosphate dehydrogenase) deficiency;
  • Anemia
  • Myasthenia
  • Pregnancy and breastfeeding
  • Allergy to ozone
  • Local infections

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

A.O. Ordine Mauriziano

Torino, 10128, Italy

RECRUITING

Related Publications (1)

  • Guaschino L, Vanzanelli A, Babando P, Ricotti A, Ramieri GA, Roccuzzo A, Appendino P. Effect of ozone therapy on post-operative pain following mandibular third molar surgical extraction: a split-mouth randomized clinical trial. Clin Oral Investig. 2025 Dec 9;30(1):2. doi: 10.1007/s00784-025-06681-y.

Central Study Contacts

Paolo Appendino, Dr.

CONTACT

Lucia Borsotti, dr.ssa

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2023

First Posted

July 18, 2023

Study Start

July 19, 2022

Primary Completion

July 1, 2023

Study Completion

July 19, 2023

Last Updated

July 18, 2023

Record last verified: 2023-07

Locations